12/3
08:44 am
sprb
Spruce Biosciences (NASDAQ:SPRB) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock.
Medium
Report
Spruce Biosciences (NASDAQ:SPRB) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock.
12/3
08:42 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
12/3
06:35 am
sprb
Spruce Biosciences upgraded to Outperform from Market Perform at Leerink
Low
Report
Spruce Biosciences upgraded to Outperform from Market Perform at Leerink
12/3
06:11 am
sprb
Spruce Biosciences upgraded to Outperform from Market Perform at Leerink
Low
Report
Spruce Biosciences upgraded to Outperform from Market Perform at Leerink
11/11
07:03 am
sprb
Spruce Biosciences (NASDAQ:SPRB) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Spruce Biosciences (NASDAQ:SPRB) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
10/28
09:22 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
10/28
09:22 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
10/28
07:03 am
sprb
Spruce Biosciences (NASDAQ:SPRB) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.
Medium
Report
Spruce Biosciences (NASDAQ:SPRB) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.
10/21
04:48 pm
sprb
Rating for SPRB
Medium
Report
Rating for SPRB